2 research outputs found

    Efficacy of wheat-based biscuits fortified with microcapsules containing ferrous sulfate and potassium iodate or a new hydrogen-reduced elemental iron: a randomised, double-blind, controlled trial in Kuwaiti women

    Get PDF
    Adverse sensory changes prevent the addition of highly bioavailable ferrous sulfate (FeSO4) to most wheat flours. Poorly absorbable reduced Fe powders are commonly used. Encapsulation of FeSO4 can overcome these sensory changes, but the particle size of commercial compounds is too large to be used by flour mills. The first objective of the study was to measure the efficacy in wheat flour of two newly developed Fe compounds, an H-reduced Fe powder (NutraFineā„¢ RS; North America HƶganƤs High Alloys LLC, Johnstown, PA, USA) and small particle-sized (40Ī¼m) encapsulated FeSO4. As a second objective, the microcapsules were evaluated as a vehicle for iodine fortification. A randomised, double-blind controlled intervention trial was conducted in Kuwaiti women (n 279; aged 18-35 years) with low body Fe stores (serum ferritin (SF) <25Ī¼g/l) randomly assigned to one of three groups (20mg Fe as NutraFineā„¢ RS, 10mg Fe as encapsulated FeSO4 and 150Ī¼g iodine, or no fortification Fe) who consumed wheat-based biscuits 5d per week. At baseline and 22 weeks, Hb, SF, transferrin receptor, urinary iodine and body Fe stores were measured. Relative to control, mean SF in the encapsulated FeSO4 group increased by 88% (P<0Ā·001) and body Fe stores increased from āˆ’0Ā·96 to 2Ā·24mg/kg body weight (P<0Ā·001), while NutraFineā„¢ RS did not significantly increase SF or body Fe stores. The median urinary iodine concentration increased from 140 to 213Ī¼g/l (P<0Ā·01). NutraFineā„¢ RS added at double the amount of Fe as FeSO4 was not efficacious in improving Fe status. The newly developed microcapsules were highly efficacious in improving both Fe stores and iodine statu
    corecore